BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas. J Gastrointest Surg. 2012;16:682-691. [PMID: 22350721 DOI: 10.1007/s11605-011-1808-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review. Asian J Surg 2019;42:46-52. [PMID: 29802028 DOI: 10.1016/j.asjsur.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Hank T, Klaiber U, Sahora K, Schindl M, Strobel O. [Surgery for periampullary pancreatic cancer]. Chirurg 2021;92:776-87. [PMID: 34259884 DOI: 10.1007/s00104-021-01462-1] [Reference Citation Analysis]
3 Augustin T, Moslim MA, Cengiz TB, El-Hayek K, Simon R, Bhatt A, Tang A, Burke CA, Matthew Walsh R. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer. J Surg Oncol 2020;122:1132-44. [PMID: 33124067 DOI: 10.1002/jso.26131] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mielko J, Kurylcio A, Skórzewska M, Ciseł B, Polkowska B, Rawicz-Pruszyński K, Sierocińska-Sawa J, Polkowski WP. Duodenal obstruction due to annular pancreas associated with carcinoma of the duodenum. Prz Gastroenterol 2016;11:139-42. [PMID: 27350844 DOI: 10.5114/pg.2016.57885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Jiang S, Zhao R, Li Y, Han X, Liu Z, Ge W, Dong Y, Han W. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database. Sci Rep 2018;8:7940. [PMID: 29786691 DOI: 10.1038/s41598-018-26145-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
6 Golhar A, Mangla V, Mehrotra S, Lalwani S, Mehta N, Nundy S. Limited distal duodenal resection: Surgical approach and outcomes. A case series. Ann Med Surg (Lond) 2018;30:36-41. [PMID: 30013770 DOI: 10.1016/j.amsu.2018.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board. Diagnosis of digestive system tumours. Int J Cancer 2021;148:1040-50. [PMID: 32674220 DOI: 10.1002/ijc.33210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Wang W, Liu Q, Zhao ZM, Tan XL, Wang ZZ, Zhang KD, Liu R. Comparison of robotic and open pancreaticoduodenectomy for primary nonampullary duodenal adenocarcinoma: a retrospective cohort study. Langenbecks Arch Surg 2021. [PMID: 34471952 DOI: 10.1007/s00423-021-02303-9] [Reference Citation Analysis]
9 Platoff RM, Kellish AS, Hakim A, Gaughan JP, Atabek UM, Spitz FR, Hong YK. Simple Versus Radical Resection for Duodenal Adenocarcinoma: A Propensity Score Matched Analysis of National Cancer Database. Am Surg 2021;87:266-75. [PMID: 32927979 DOI: 10.1177/0003134820951432] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Chen ZH, Qiu MZ, Wu XY, Wu QN, Lu JH, Zeng ZL, Wang Y, Wei XL, Wang F, Xu RH. Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients. J Cancer 2018;9:512-20. [PMID: 29483956 DOI: 10.7150/jca.22305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Mao EJ, Watson JB, Soares G, Habr FG. Successful percutaneous endobiliary radiofrequency ablation for unresectable malignant biliary obstruction: a case report and review of the literature. J Gastrointest Cancer. 2014;45 Suppl 1:55-57. [PMID: 23975623 DOI: 10.1007/s12029-013-9538-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Blanco-Fernández G, Rojas-Holguín A, De-Armas-Conde N, Gallarín-Salamanca I, López-Guerra D, Jaén-Torrejimeno I. Side-to-side duodenojejunostomy after resection of third and fourth duodenal portions with pancreatic preservation. Updates Surg 2020;72:1105-13. [PMID: 32504267 DOI: 10.1007/s13304-020-00823-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mann K, Gilbert T, Cicconi S, Jackson R, Whelan P, Campbell F, Halloran C, Neoptolemos J, Ghaneh P. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. Langenbecks Arch Surg 2019;404:439-49. [PMID: 30972486 DOI: 10.1007/s00423-019-01779-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
14 Ohtsuka M, Miyazaki M. Long-Term Survival After Resection of Periampullary Cancer. In: Beger HG, Warshaw AL, Hruban RH, Büchler MW, Lerch MM, Neoptolemos JP, Shimosegawa T, Whitcomb DC, Groß C, editors. The Pancreas. Chichester: John Wiley & Sons, Ltd; 2018. pp. 1097-106. [DOI: 10.1002/9781119188421.ch146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Malleo G, Tonsi A, Marchegiani G, Casarotto A, Paiella S, Butturini G, Salvia R, Bassi C. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. Langenbecks Arch Surg. 2013;398:287-294. [PMID: 22801737 DOI: 10.1007/s00423-012-0978-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang H, Ning Z, Li Y, Zhu X, Meng Z. Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Mol Med Rep 2016;14:1907-14. [PMID: 27432228 DOI: 10.3892/mmr.2016.5471] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
17 Meijer LL, Strijker M, de Bakker JK, Toennaer JG, Zonderhuis BM, van der Vliet HJ, Wilmink H, Verheij J, Daams F, Busch OR, van Grieken NC, Besselink MG, Kazemier G. Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma. World J Gastrointest Oncol 2020; 12(3): 347-357 [PMID: 32206184 DOI: 10.4251/wjgo.v12.i3.347] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Téoule P, Distler M, Niedergethmann M, Gaiser T, Rückert F, Grützmann R, Wilhelm TJ. Retrospective analysis of prognostic factors in patients with duodenal adenocarcinoma. Eur Surg 2016;48:228-34. [DOI: 10.1007/s10353-015-0374-0] [Reference Citation Analysis]
19 Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018;25:2681-2692. [PMID: 29946997 DOI: 10.1245/s10434-018-6567-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
20 Shiba S, Miki A, Ohzawa H, Teratani T, Sakuma Y, Lefor AK, Kitayama J, Sata N. Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma. Journal of Surgical Research 2019;238:79-89. [DOI: 10.1016/j.jss.2019.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang N, Bu Q, Liu Q, Yang J, He H, Liu J, Ren X, Lyu J. Effect of marital status on duodenal adenocarcinoma survival: A Surveillance Epidemiology and End Results population analysis. Oncol Lett 2019;18:1904-14. [PMID: 31423260 DOI: 10.3892/ol.2019.10475] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Cloyd JM, George E, Visser BC. Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg 2016; 8(3): 212-221 [PMID: 27022448 DOI: 10.4240/wjgs.v8.i3.212] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
23 Solaini L, Jamieson NB, Metcalfe M, Abu Hilal M, Soonawalla Z, Davidson BR, McKay C, Kocher HM; UK Duodenal Cancer Study Group. Outcome after surgical resection for duodenal adenocarcinoma in the UK. Br J Surg. 2015;102:676-681. [PMID: 25776995 DOI: 10.1002/bjs.9791] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
24 Nortunen M, Parkkila S, Saarnio J, Huhta H, Karttunen TJ. Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma. J Histochem Cytochem 2021;69:677-90. [PMID: 34636283 DOI: 10.1369/00221554211050133] [Reference Citation Analysis]
25 Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database. Int J Clin Oncol 2018;23:473-81. [DOI: 10.1007/s10147-017-1226-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Li A, Morton JP, Ma Y, Karim SA, Zhou Y, Faller WJ, Woodham EF, Morris HT, Stevenson RP, Juin A, Jamieson NB, MacKay CJ, Carter CR, Leung HY, Yamashiro S, Blyth K, Sansom OJ, Machesky LM. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology 2014;146:1386-96.e1-17. [PMID: 24462734 DOI: 10.1053/j.gastro.2014.01.046] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
27 Sakamoto T, Saiura A, Ono Y, Mise Y, Inoue Y, Ishizawa T, Takahashi Y, Ito H. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter? Ann Surg Oncol 2017;24:3368-75. [PMID: 28799027 DOI: 10.1245/s10434-017-6044-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
28 Ye N, Bao X, Zhao X, Wang B. Signet-ring cell carcinoma of the duodenal bulb presenting with gastrointestinal hemorrhage: a case report and literature review. BMC Gastroenterol 2022;22:226. [PMID: 35534806 DOI: 10.1186/s12876-022-02267-0] [Reference Citation Analysis]
29 Margonis GA, Samaha M, Kim Y, Postlewait LM, Kunz P, Maithel S, Tran T, Berger N, Gamblin TC, Mullen MG. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. J Gastrointest Surg. 2016;20:1098-1105. [PMID: 27008594 DOI: 10.1007/s11605-016-3135-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
30 Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal carcinomas. Surg Oncol. 2015;24:110-116. [PMID: 25936244 DOI: 10.1016/j.suronc.2015.04.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
31 Dave A, Wiseman JT, Cloyd JM. Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies. Expert Opinion on Orphan Drugs 2019;7:463-72. [DOI: 10.1080/21678707.2019.1684257] [Reference Citation Analysis]
32 Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018;13:e0200204. [PMID: 30096150 DOI: 10.1371/journal.pone.0200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Buanes TA. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research. World J Gastroenterol 2016; 22(48): 10502-10511 [PMID: 28082802 DOI: 10.3748/wjg.v22.i48.10502] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Burasakarn P, Higuchi R, Nunobe S, Kanaji S, Eguchi H, Okada KI, Fujii T, Nagakawa Y, Kanetaka K, Yamashita H, Yamada S, Kuroda S, Aoyama T, Akahori T, Nakagawa K, Yamamoto M, Yamaue H, Sho M, Kodera Y; Japan Duodenal Cancer Guideline Committee. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol 2021;26:450-60. [PMID: 33386555 DOI: 10.1007/s10147-020-01840-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Xue Y, Vanoli A, Balci S, Reid MM, Saka B, Bagci P, Memis B, Choi H, Ohike N, Tajiri T, Muraki T, Quigley B, El-rayes BF, Shaib W, Kooby D, Sarmiento J, Maithel SK, Knight JH, Goodman M, Krasinskas AM, Adsay V. Non-ampullary–duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. Mod Pathol 2017;30:255-66. [DOI: 10.1038/modpathol.2016.174] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]